Within sight of a rational pipeline for development of protein diagnostics

Clinical Chemistry

Volumn 58, Issue 1, 2012, Pages 28-30

  Anderson, Leigh ^a  

^a The Plasma Proteome Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; MYELOPEROXIDASE; MYOGLOBIN; TROPONIN T;

ALZHEIMER DISEASE; BREAST CANCER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY SINUS; CORONARY SINUS BLOOD FLOW; EXERCISE TEST; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOASSAY; MASS SCREENING; MASS SPECTROMETER; MASS SPECTROMETRY; NONHUMAN; PROTEOMICS; QUALITY CONTROL; SHORT SURVEY; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MASS SPECTROMETRY; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM;

EID: 84856073391     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.173377     Document Type: Short Survey

References (4)

1. Anderson NL. The Clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin Chem 2010;56:177-85.
2. Ptolemy AS, Rifai N. What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema. Scand J Clin Lab Invest Suppl 2010;242:6-14.
3. Addona TA, Shi X, Keshishian H, Mani DR, Burgess M, Gillette MA, et al. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat Biotechnol 2011; 29:635-43.
4. Whiteaker JR, Lin C, Kennedy J, Hou L, Trute M, Sokal I, et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat Biotechnol 2011;29:625-34.